Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors.

Yang MX, Coates RF, Ambaye A, Cortright V, Mitchell JM, Buskey AM, Zubarik R, Liu JG, Ades S, Barry MM.

Biomark Res. 2018 Apr 18;6:15. doi: 10.1186/s40364-018-0129-8. eCollection 2018.

2.

Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention.

Farina NH, Zingiryan A, Vrolijk MA, Perrapato SD, Ades S, Stein GS, Lian JB, Landry CC.

J Cell Physiol. 2018 Sep;233(9):6408-6417. doi: 10.1002/jcp.26593. Epub 2018 Apr 16. Review.

3.

Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.

Ades S, Douce D, Holmes CE, Cory S, Prior S, Butenas S, Callas P, Cushman M.

J Thromb Haemost. 2018 Jun;16(6):1099-1106. doi: 10.1111/jth.14004. Epub 2018 Apr 29.

PMID:
29575637
4.

Allosteric Effector ppGpp Potentiates the Inhibition of Transcript Initiation by DksA.

Molodtsov V, Sineva E, Zhang L, Huang X, Cashel M, Ades SE, Murakami KS.

Mol Cell. 2018 Mar 1;69(5):828-839.e5. doi: 10.1016/j.molcel.2018.01.035. Epub 2018 Feb 22.

5.

Circuitry Linking the Global Csr- and σE-Dependent Cell Envelope Stress Response Systems.

Yakhnin H, Aichele R, Ades SE, Romeo T, Babitzke P.

J Bacteriol. 2017 Oct 31;199(23). pii: e00484-17. doi: 10.1128/JB.00484-17. Print 2017 Dec 1.

6.

Themes and variations in gene regulation by extracytoplasmic function (ECF) sigma factors.

Sineva E, Savkina M, Ades SE.

Curr Opin Microbiol. 2017 Apr;36:128-137. doi: 10.1016/j.mib.2017.05.004. Epub 2017 May 30. Review.

7.

Appropriate Regulation of the σE-Dependent Envelope Stress Response Is Necessary To Maintain Cell Envelope Integrity and Stationary-Phase Survival in Escherichia coli.

Nicoloff H, Gopalkrishnan S, Ades SE.

J Bacteriol. 2017 May 25;199(12). pii: e00089-17. doi: 10.1128/JB.00089-17. Print 2017 Jun 15.

8.

Teaching broader impacts of science with undergraduate research.

Keiler KC, Jackson KL, Jaworski L, Lopatto D, Ades SE.

PLoS Biol. 2017 Mar 21;15(3):e2001318. doi: 10.1371/journal.pbio.2001318. eCollection 2017 Mar.

9.

Effectiveness of aprepitant in addition to ondansetron in the prevention of nausea and vomiting caused by fractionated radiotherapy to the upper abdomen (AVERT).

Ades S, Halyard M, Wilson K, Ashikaga T, Heimann R, Kumar S, Blackstock W.

Support Care Cancer. 2017 May;25(5):1503-1510. doi: 10.1007/s00520-016-3540-4. Epub 2016 Dec 28.

PMID:
28032216
10.

When Clinical Trial Participation Is Not an Option in the Era of Personalized Medicine: The Case of Two Patients.

Verschraegen CF, Rehman H, Pulluri B, DeKay J, Barry M, Folefac E, Dittus K, Holmes C, Sprague J, Ades S, Gibson PC.

Oncology. 2017;92(1):55-60. doi: 10.1159/000450712. Epub 2016 Nov 8.

PMID:
27820931
11.

Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.

Mori M, Ji Y, Kumar S, Ashikaga T, Ades S.

Int J Clin Oncol. 2017 Apr;22(2):397-404. doi: 10.1007/s10147-016-1041-6. Epub 2016 Sep 15.

PMID:
27628064
12.

Randomized phase II study of loratadine for the prevention of bone pain caused by pegfilgrastim.

Moukharskaya J, Abrams DM, Ashikaga T, Khan F, Schwartz J, Wilson K, Verschraegen C, Openshaw T, Valentine J, Eneman J, Unger P, Ades S.

Support Care Cancer. 2016 Jul;24(7):3085-93. doi: 10.1007/s00520-016-3119-0. Epub 2016 Feb 19.

13.

Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer.

Ades S, Kumar S, Alam M, Goodwin A, Weckstein D, Dugan M, Ashikaga T, Evans M, Verschraegen C, Holmes CE.

J Thromb Haemost. 2015 Jun;13(6):998-1003. doi: 10.1111/jth.12910. Epub 2015 Apr 23.

14.

Delayed human herpes virus 6 encephalitis in a patient with allogeneic stem cell transplant.

O'Toole J, Ades S, Waters BL, Agarwal Z, Lamba G.

Leuk Lymphoma. 2015;56(9):2709-10. doi: 10.3109/10428194.2014.1003054. Epub 2015 Feb 11. No abstract available.

PMID:
25629987
15.

Identification of inhibitors of a bacterial sigma factor using a new high-throughput screening assay.

El-Mowafi SA, Sineva E, Alumasa JN, Nicoloff H, Tomsho JW, Ades SE, Keiler KC.

Antimicrob Agents Chemother. 2015 Jan;59(1):193-205. doi: 10.1128/AAC.03979-14. Epub 2014 Oct 20.

16.

Survival and recurrence patterns after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophagogastric adenocarcinoma.

Sudarshan M, Alcindor T, Ades S, Aloraini A, van Huyse M, Asselah J, David M, Frechette D, Brisson S, Thirlwell M, Ferri L.

Ann Surg Oncol. 2015 Jan;22(1):324-30. doi: 10.1245/s10434-014-3875-3. Epub 2014 Jul 15.

PMID:
25023544
17.

Cell-based assay to identify inhibitors of the Hfq-sRNA regulatory pathway.

El-Mowafi SA, Alumasa JN, Ades SE, Keiler KC.

Antimicrob Agents Chemother. 2014 Sep;58(9):5500-9. doi: 10.1128/AAC.03311-14. Epub 2014 Jul 7.

18.
19.

Absence of anaplastic lymphoma kinase translocations in signet ring cell carcinomas of the upper gastrointestinal tract.

Miller J, Peng Z, Wilcox R, Evans M, Ades S, Verschraegen C.

Gastrointest Cancer Res. 2014 Mar;7(2):39-41.

20.

Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis.

Adams NB, Lutsey PL, Folsom AR, Herrington DH, Sibley CT, Zakai NA, Ades S, Burke GL, Cushman M.

J Thromb Haemost. 2013 Jun;11(6):1078-84. doi: 10.1111/jth.12223.

21.

Regulated proteolysis: control of the Escherichia coli σ(E)-dependent cell envelope stress response.

Barchinger SE, Ades SE.

Subcell Biochem. 2013;66:129-60. doi: 10.1007/978-94-007-5940-4_6. Review.

PMID:
23479440
22.

Perioperative DCF chemotherapy protocol for patients with gastroesophageal adenocarcinoma: correlation between response to treatment and outcome.

Alcindor T, Ferri LE, Marcus V, Andalib A, Hickeson M, Artho G, Chasen M, Thirlwell MP, Ades S.

Med Oncol. 2013 Mar;30(1):377. doi: 10.1007/s12032-012-0377-7. Epub 2012 Dec 29.

PMID:
23275118
23.

In-advance end-of-life discussions and the quality of inpatient end-of-life care: a pilot study in bereaved primary caregivers of advanced cancer patients.

Mori M, Ellison D, Ashikaga T, McVeigh U, Ramsay A, Ades S.

Support Care Cancer. 2013 Feb;21(2):629-36. doi: 10.1007/s00520-012-1581-x. Epub 2012 Aug 30.

PMID:
22933133
24.

sigE facilitates the adaptation of Bordetella bronchiseptica to stress conditions and lethal infection in immunocompromised mice.

Barchinger SE, Zhang X, Hester SE, Rodriguez ME, Harvill ET, Ades SE.

BMC Microbiol. 2012 Aug 16;12:179. doi: 10.1186/1471-2180-12-179.

25.

Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial.

Ferri LE, Ades S, Alcindor T, Chasen M, Marcus V, Hickeson M, Artho G, Thirlwell MP.

Ann Oncol. 2012 Jun;23(6):1512-7. doi: 10.1093/annonc/mdr465. Epub 2011 Oct 29.

PMID:
22039085
26.

Physiological response to membrane protein overexpression in E. coli.

Gubellini F, Verdon G, Karpowich NK, Luff JD, Boël G, Gauthier N, Handelman SK, Ades SE, Hunt JF.

Mol Cell Proteomics. 2011 Oct;10(10):M111.007930. doi: 10.1074/mcp.M111.007930. Epub 2011 Jun 30.

27.

Promoter strength properties of the complete sigma E regulon of Escherichia coli and Salmonella enterica.

Mutalik VK, Nonaka G, Ades SE, Rhodius VA, Gross CA.

J Bacteriol. 2009 Dec;191(23):7279-87. doi: 10.1128/JB.01047-09. Epub 2009 Sep 25.

28.

Adjuvant chemotherapy for colon cancer in the elderly: moving from evidence to practice.

Ades S.

Oncology (Williston Park). 2009 Feb;23(2):162-7. Review.

29.

Regulation by destruction: design of the sigmaE envelope stress response.

Ades SE.

Curr Opin Microbiol. 2008 Dec;11(6):535-40. doi: 10.1016/j.mib.2008.10.004. Epub 2008 Nov 7. Review.

PMID:
18983936
30.

Selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia.

Ades S, Koushik A, Duarte-Franco E, Mansour N, Arseneau J, Provencher D, Gilbert L, Gotlieb W, Ferenczy A, Coutlée F, Roger M, Franco EL; Biomarkers of Cervical Cancer Risk (BCCR) Study Team.

Int J Cancer. 2008 Jun 15;122(12):2820-6. doi: 10.1002/ijc.23459.

31.

The extracytoplasmic stress factor, sigmaE, is required to maintain cell envelope integrity in Escherichia coli.

Hayden JD, Ades SE.

PLoS One. 2008 Feb 6;3(2):e1573. doi: 10.1371/journal.pone.0001573.

32.

The Rcs phosphorelay is a cell envelope stress response activated by peptidoglycan stress and contributes to intrinsic antibiotic resistance.

Laubacher ME, Ades SE.

J Bacteriol. 2008 Mar;190(6):2065-74. doi: 10.1128/JB.01740-07. Epub 2008 Jan 11.

33.

ppGpp and DksA likely regulate the activity of the extracytoplasmic stress factor sigmaE in Escherichia coli by both direct and indirect mechanisms.

Costanzo A, Nicoloff H, Barchinger SE, Banta AB, Gourse RL, Ades SE.

Mol Microbiol. 2008 Feb;67(3):619-32. Epub 2007 Dec 12.

35.

Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.

Ades S, Maxfield LF, Gould CJ, Jones GK, Levy SB.

Int J Oncol. 2006 Mar;28(3):747-53.

PMID:
16465381
36.

AAA+ molecular machines: firing on all cylinders.

Ades SE.

Curr Biol. 2006 Jan 24;16(2):R46-8. No abstract available.

37.

Proteolysis: Adaptor, adaptor, catch me a catch.

Ades SE.

Curr Biol. 2004 Nov 9;14(21):R924-6. Review.

38.

Control of the alternative sigma factor sigmaE in Escherichia coli.

Ades SE.

Curr Opin Microbiol. 2004 Apr;7(2):157-62. Review.

PMID:
15063853
40.

Lens changes in hereditary hyperferritinemia-cataract syndrome.

Chang-Godinich A, Ades S, Schenkein D, Brooks D, Stambolian D, Raizman MB.

Am J Ophthalmol. 2001 Nov;132(5):786-8.

PMID:
11704046
41.
42.

Insect immunity. Isolation from the lepidopteran Heliothis virescens of a novel insect defensin with potent antifungal activity.

Lamberty M, Ades S, Uttenweiler-Joseph S, Brookhart G, Bushey D, Hoffmann JA, Bulet P.

J Biol Chem. 1999 Apr 2;274(14):9320-6.

43.

Breastfeeding practices and nutritional status of children at high altitude in Ladakh.

Cvejic E, Ades S, Flexer W, Gray-Donald K.

J Trop Pediatr. 1997 Dec;43(6):376. doi: 10.1093/tropej/43.6.376. No abstract available.

PMID:
9476466
44.

Engrailed (Gln50-->Lys) homeodomain-DNA complex at 1.9 A resolution: structural basis for enhanced affinity and altered specificity.

Tucker-Kellogg L, Rould MA, Chambers KA, Ades SE, Sauer RT, Pabo CO.

Structure. 1997 Aug 15;5(8):1047-54.

45.

Specificity of minor-groove and major-groove interactions in a homeodomain-DNA complex.

Ades SE, Sauer RT.

Biochemistry. 1995 Nov 7;34(44):14601-8.

PMID:
7578067
46.

Differential DNA-binding specificity of the engrailed homeodomain: the role of residue 50.

Ades SE, Sauer RT.

Biochemistry. 1994 Aug 9;33(31):9187-94.

PMID:
8049221
47.

Sequence and domain structure of talin.

Rees DJ, Ades SE, Singer SJ, Hynes RO.

Nature. 1990 Oct 18;347(6294):685-9.

PMID:
2120593
48.

Complete gastrectomy for haemorrhage.

Ades S.

Nurs Mirror Midwives J. 1967 Mar 10;123(23):529-31. No abstract available.

PMID:
5297727

Supplemental Content

Support Center